Xigen is developing innovative therapeutic peptides for a broad range of diseases with underserved medical needs and proven commercial value, with a focus on inflammation. Xigen’s technology platform enables the design and synthesis of cell-penetrating peptides with enhanced metabolic stability, using proprietary carrier motifs to selectively deliver them to intracellular targets.
 
   
Pipeline - Xigen is building a pipelineof specific, persistent, intracellular inhibitory peptides...
 
Web creation : Alchimie